Orchid Welcomes Distinguished Clinical and Genetics Leaders to its Advisory Boards
"This technology empowers prospective parents by providing comprehensive insights into their embryos' genetics, allowing for informed decisions that can contribute to a healthier start for their future child.
- "This technology empowers prospective parents by providing comprehensive insights into their embryos' genetics, allowing for informed decisions that can contribute to a healthier start for their future child.
- They are able to target a healthy life for their child," said Jerry Lanchbury, previous Chief Scientific advisor of Myriad Genetics.
- "We could not be more honored to have the support and guidance of these integral figures in reproductive medicine and genetics," said Noor Siddiqui, founder and CEO of Orchid.
- Jerry Lanchbury, Ph.D, served as the Chief Scientific Officer at Myriad Genetics, leading teams responsible for major molecular diagnostic innovations.